Acalabrutinib 00310-5512-00
- Manufacturer
- Astrazeneca Pharmaceuticals Lp
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- August 4, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Acalabrutinib Maleate Anhydrous | 100 mg/1 |
Selected Package
00310-5512-00Selected190000 TABLET, FILM COATED in 1 DRUM (0310-5512-00)